Akso Health Group (AHG) AI Stock Analysis

Akso Health Group operates a social e-commerce mobile platform based in China centered around its Xiaobai Maimai App. Through this application, the company retails food and beverages, wine, cosmetics, fashion apparel, entertainment items, housewares, and home appliances. In addition to online merchandise sales and brand promotions, Akso Health Group provides consultancy services, information technology support, health treatments, and medical device sales. Founded in 2014, headquartered in Beijing, and formerly known as Xiaobai Maimai Inc., the company rebranded in December 2021 and functions as a subsidiary of Webao Limited.

Akso Health Group generated $13.8M in revenue during FY2026, representing a decline of 6.4% compared to $14.8M in FY2025. Between FY2021 and FY2026, the company posted a 5-year revenue compound annual growth rate of 51.1%. However, profitability remains under pressure. Gross margin stood at -0.1% in FY2026, improving from -1.9% in FY2025. Net income was -$18.7M in FY2026 following a net loss of -$135.0M in FY2025. For the trailing twelve months ended June 30, 2026, revenue stood at $13.8M with a profit margin of -135.0% and an operating margin of -37.5%, while quarterly revenue declined 12.9% year-over-year.

As of June 30, 2026, Akso Health Group held $170,572 in cash and short-term investments against total debt of $375,659, resulting in net debt of $205,087. The company reported shareholders' equity of $180.9M and total assets of $189.6M. Its current ratio stood at 21.77, with a debt-to-equity ratio of 0.00. During FY2026, operating cash flow was -$12.8M and capital expenditures reached $175.7M, which contributed to free cash flow of -$188.5M. Meanwhile, the five-year share count increased by 11695.8%.

Akso Health Group carries a market capitalization of $1.16B and an enterprise value of $659.8M. The stock trades at a price-to-sales multiple of 83.6x and an enterprise value-to-revenue multiple of 47.7x, compared to the median price-to-sales multiple of 4.1x for its US-listed Healthcare peers. The company also trades at a price-to-book ratio of 3.6x. Over the past year, the shares dropped 18.7% compared to a 16.8% gain for the S&P 500, and over five years the stock declined 77.1% against an 83.0% gain for the benchmark index.

Akso Health Group had 0 EPS beats over the last 4 quarters. The company's next scheduled earnings date is October 22, 2026. The stock closed at $1.35 on October 16, 2026, trading 11.3% below its 200-day moving average.

This page is an AI-written research summary of Akso Health Group (AHG). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: AHG income statement, AHG balance sheet, AHG key metrics, AHG chart. See the AHG stock overview for the latest quote and news.